Victory Capital Management Inc Vanda Pharmaceuticals Inc. Transaction History

Victory Capital Management Inc

$95.7 Billion
Q4 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$3.47 - $4.61 $317,126 - $421,312	91,391 Added 72.92%	216,717 $890,000
Q4 2023 Feb 05, 2024	SELL	$3.38 - $4.58 $73,386 - $99,440	-21,712 Reduced 14.77%	125,326 $528,000
Q3 2023 Nov 06, 2023	SELL	$4.28 - $6.57 $14,393 - $22,094	-3,363 Reduced 2.24%	147,038 $635,000
Q2 2023 Jul 27, 2023	SELL	$5.9 - $6.95 $502,933 - $592,438	-85,243 Reduced 36.17%	150,401 $991,000
Q1 2023 May 02, 2023	SELL	$6.18 - $7.99 $268,267 - $346,837	-43,409 Reduced 15.56%	235,644 $1.6 Million
Q4 2022 Feb 10, 2023	SELL	$6.87 - $10.96 $60,153 - $95,965	-8,756 Reduced 3.04%	279,053 $2.06 Million
Q4 2022 Feb 09, 2023	SELL	$6.87 - $10.96 $30,440 - $48,563	-4,431 Reduced 1.52%	287,809 $2.13 Million
Q3 2022 Nov 02, 2022	BUY	$9.44 - $11.76 $172,988 - $215,502	18,325 Added 6.69%	292,240 $2.89 Million
Q2 2022 Aug 01, 2022	BUY	$9.31 - $11.84 $142,759 - $181,554	15,334 Added 5.93%	273,915 $2.99 Million
Q1 2022 May 04, 2022	SELL	$10.84 - $16.55 $22,829 - $34,854	-2,106 Reduced 0.81%	258,581 $2.83 Million
Q4 2021 Feb 07, 2022	BUY	$15.69 - $21.14 $81,619 - $109,970	5,202 Added 2.04%	260,687 $4.09 Million
Q3 2021 Nov 02, 2021	BUY	$15.35 - $21.27 $1.83 Million - $2.54 Million	119,259 Added 87.54%	255,485 $4.38 Million
Q2 2021 Aug 03, 2021	BUY	$15.71 - $21.51 $1.33 Million - $1.82 Million	84,772 Added 164.75%	136,226 $2.93 Million
Q1 2021 May 04, 2021	BUY	$13.42 - $20.28 $356,770 - $539,143	26,585 Added 106.9%	51,454 $773,000
Q4 2020 Feb 01, 2021	BUY	$9.77 - $13.81 $70,822 - $100,108	7,249 Added 41.14%	24,869 $327,000
Q3 2020 Nov 09, 2020	BUY	$9.32 - $12.02 $164,218 - $211,792	17,620 New	17,620 $170,000
Q2 2020 Aug 07, 2020	SELL	$9.66 - $12.02 $70,923 - $88,250	-7,342 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$7.5 - $16.8 $21,360 - $47,846	-2,848 Reduced 27.95%	7,342 $76,000
Q4 2019 Feb 06, 2020	BUY	$12.38 - $17.47 $33,723 - $47,588	2,724 Added 36.49%	10,190 $167,000
Q4 2019 Feb 04, 2020	SELL	$12.38 - $17.47 $7,923 - $11,180	-640 Reduced 7.9%	7,466 $95,000
Q3 2019 Nov 12, 2019	BUY	$12.27 - $15.79 $64,319 - $82,771	5,242 Added 183.03%	8,106 $108,000
Q2 2019 Aug 15, 2019	SELL	$13.37 - $18.85 $66,555 - $93,835	-4,978 Reduced 63.48%	2,864 $40,000
Q1 2019 May 03, 2019	BUY	$17.59 - $31.05 $137,940 - $243,494	7,842 New	7,842 $144,000

Others Institutions Holding VNDA

# of Institutions

154

Shares Held

43.8M

Call Options Held

33.8K

Put Options Held

28.7K

Black Rock Inc. New York, NY

8.14M
Shares

$36 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

3.85M
Shares

$17 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

3.51M
Shares

$15.5 Million
0.0% of portfolio
Dimensional Fund Advisors LP Austin, TX

2.49M
Shares

$11 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

2.35M
Shares

$10.4 Million
0.85% of portfolio

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $250M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account